Natco Pharma Limited Cash Flow Conversion Efficiency
Natco Pharma Limited cash flow conversion efficiency. Based on the latest financial reports, Natco Pharma Limited (NATCOPHARM) has a cash flow conversion efficiency ratio of 0.138x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs11.91 Billion ≈ $128.76 Million USD) by net assets (Rs86.54 Billion ≈ $935.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Natco Pharma Limited (2005–2025)
Cash flow conversion efficiency of Natco Pharma Limited from 2005 to 2025. This chart illustrates how Natco Pharma Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View NATCOPHARM stock price and chart for real-time trading data and today's change.
Natco Pharma Limited Cash Flow Conversion Ratio Explained
Natco Pharma Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Natco Pharma Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Natco Pharma Limited ranked by their cash flow conversion efficiency. Also see NATCOPHARM stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Premier Investments Ltd
AU:PMV
|
0.041x |
|
Northking Information Technology Co
SHE:002987
|
0.027x |
|
Macmahon Holdings Ltd
AU:MAH
|
0.187x |
|
Beach Energy Ltd
AU:BPT
|
0.140x |
|
Lakeland Financial Corporation
NASDAQ:LKFN
|
0.047x |
|
Ningxia Jiaze Renewables Corp
SHG:601619
|
0.189x |
|
NV5 Global Inc
NASDAQ:NVEE
|
0.014x |
|
Xinjiang Tecon Animal Husbandry Bio-Technology Co Ltd
SHE:002100
|
0.087x |
Annual Cash Flow Conversion Efficiency for Natco Pharma Limited (2005–2025)
The table below shows the annual cash flow conversion efficiency of Natco Pharma Limited from 2005 to 2025. Review Natco Pharma Limited free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs76.12 Billion ≈ $823.24 Million |
Rs16.97 Billion ≈ $183.50 Million |
0.223x | +4.18% |
| 2024-03-31 | Rs58.53 Billion ≈ $632.99 Million |
Rs12.52 Billion ≈ $135.43 Million |
0.214x | +130.24% |
| 2023-03-31 | Rs91.37 Billion ≈ $988.18 Million |
Rs8.49 Billion ≈ $91.83 Million |
0.093x | +752.04% |
| 2022-03-31 | Rs42.64 Billion ≈ $461.09 Million |
Rs465.00 Million ≈ $5.03 Million |
0.011x | -84.95% |
| 2021-03-31 | Rs41.23 Billion ≈ $445.93 Million |
Rs2.99 Billion ≈ $32.31 Million |
0.072x | -34.28% |
| 2020-03-31 | Rs37.85 Billion ≈ $409.30 Million |
Rs4.17 Billion ≈ $45.13 Million |
0.110x | -42.45% |
| 2019-03-31 | Rs34.91 Billion ≈ $377.54 Million |
Rs6.69 Billion ≈ $72.33 Million |
0.192x | +27.11% |
| 2018-03-31 | Rs30.76 Billion ≈ $332.66 Million |
Rs4.64 Billion ≈ $50.14 Million |
0.151x | -27.94% |
| 2017-03-31 | Rs16.53 Billion ≈ $178.81 Million |
Rs3.46 Billion ≈ $37.40 Million |
0.209x | +166.23% |
| 2016-03-31 | Rs13.03 Billion ≈ $140.94 Million |
Rs1.02 Billion ≈ $11.07 Million |
0.079x | -27.85% |
| 2015-03-31 | Rs8.51 Billion ≈ $92.04 Million |
Rs926.66 Million ≈ $10.02 Million |
0.109x | -44.61% |
| 2014-03-31 | Rs7.33 Billion ≈ $79.24 Million |
Rs1.44 Billion ≈ $15.58 Million |
0.197x | +74.77% |
| 2013-03-31 | Rs5.44 Billion ≈ $58.84 Million |
Rs611.95 Million ≈ $6.62 Million |
0.112x | -18.24% |
| 2012-03-31 | Rs4.72 Billion ≈ $51.05 Million |
Rs649.41 Million ≈ $7.02 Million |
0.138x | -28.06% |
| 2011-03-31 | Rs3.53 Billion ≈ $38.23 Million |
Rs675.97 Million ≈ $7.31 Million |
0.191x | -23.21% |
| 2010-03-31 | Rs3.11 Billion ≈ $33.60 Million |
Rs773.69 Million ≈ $8.37 Million |
0.249x | +77.24% |
| 2009-03-31 | Rs2.66 Billion ≈ $28.77 Million |
Rs373.85 Million ≈ $4.04 Million |
0.141x | -34.64% |
| 2008-03-31 | Rs2.25 Billion ≈ $24.34 Million |
Rs483.90 Million ≈ $5.23 Million |
0.215x | -11.13% |
| 2007-03-31 | Rs1.86 Billion ≈ $20.12 Million |
Rs450.03 Million ≈ $4.87 Million |
0.242x | +19.35% |
| 2006-03-31 | Rs1.54 Billion ≈ $16.64 Million |
Rs311.81 Million ≈ $3.37 Million |
0.203x | -52.96% |
| 2005-03-31 | Rs1.14 Billion ≈ $12.29 Million |
Rs489.69 Million ≈ $5.30 Million |
0.431x | -- |
About Natco Pharma Limited
NATCO Pharma Limited, a pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; a… Read more